News & Media

Take a closer look at what we’re doing across Teva worldwide

Press releases
Oct 21 / 2020
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio
Read more
Oct 7 / 2020
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfrm) Injection Published in Headache
Read more
Oct 2 / 2020
Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) Tablets in the U.S.
Read more
Oct 1 / 2020
Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020
Read more
Top Stories
Read the latest Teva news
Our Commitment to HIV

For years, Teva has supported patients living with HIV and we continue to do so by delivering quality, cost-effective treatment options to patients. Let’s look at some facts.

Read more
Global Diversity Awareness Month

Teva is commemorating Diversity Awareness Month by sharing perspectives from our Employee Resource Group (ERG) leadership  


Read more
Meet the Expert – Mike Smith, Associate Director for Global Principal Technology

I used to design telephones but I find this far more rewarding”

Read more
Hispanic Heritage Month

Latinx ERG Celebrates Hispanic Heritage Month

Read more